Replies to post #184968 on Amarin Corp Plc (AMRN)

[Biobillionair]

Sure thing...last I looked the cases branched in two directions California Central (Omax) DS requested in a proposed order:

The motion of defendant Omax Health, Inc. (“Omax”) to dismiss or stay this the
action by plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland, Ltd.
(collectively, “Amarin” or “Plaintiffs”) came to be heard by the Court on May 3, 2019.
The Court, having read and considered Omax’s motion and all submissions of
counsel, and GOOD CAUSE appearing therefore,
IT IS HERBY ORDERED that Omax’s motion is GRANTED, and the Court
hereby [DISMISSES the Complaint in this action] [STAYS the Complaint in this action
pending final resolution of the appeal of Amarin’s complaint to the International Trade
Commission].

And

Southern Court:

Upon consideration of the parties’ notice of settlement in principle, it is hereby
ORDERED that the briefing schedule on the pending motion to dismiss is AMENDED as
follows: (1) Plaintiffs shall file their opposition on or before April 24, 2019; and (2)
Defendant shall file its reply on or before May 3, 2019. Absolutely no further extensions
will be given. If a joint motion to dismiss in light of the settlement is not filed by April 24,
2019, then Plaintiffs must file their opposition on that date.
It is SO ORDERED.
Dated: March 22, 2019

Omega is praying for an ITC ruling.... (Central Court) and Coromega is hoping for settlement prior to 4-24.

Meanwhile nothing on ITC since 6-8-2018.

IMO ITC ruling should be any day.....

BB